Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(33.3%)
Phase 4
1(33.3%)
N/A
1(33.3%)
3Total
Phase 1(1)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04823533Not ApplicableCompleted

Improving Wellbeing Through the Brain-Gut-Microbiota Axis

Role: collaborator

NCT01005849Phase 4Terminated

Probiotics and the Prevention of Traveler's Diarrhea

Role: lead

NCT00852865Phase 1Completed

Lactobacillus Farciminis and Hyperalgesia

Role: lead

All 3 trials loaded